<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK6852" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK6852/" /><meta name="ncbi_pagename" content="Pyruvate Carboxylase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Pyruvate Carboxylase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Pyruvate Carboxylase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/01" /><meta name="citation_author" content="Dong Wang" /><meta name="citation_author" content="Darryl De Vivo" /><meta name="citation_pmid" content="20301764" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK6852/" /><meta name="citation_keywords" content="Pyruvate carboxylase, mitochondrial" /><meta name="citation_keywords" content="PC" /><meta name="citation_keywords" content="Pyruvate Carboxylase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Pyruvate Carboxylase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Dong Wang" /><meta name="DC.Contributor" content="Darryl De Vivo" /><meta name="DC.Date" content="2018/03/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK6852/" /><meta name="description" content="Pyruvate carboxylase (PC) deficiency is characterized in most affected individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized:" /><meta name="og:title" content="Pyruvate Carboxylase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Pyruvate carboxylase (PC) deficiency is characterized in most affected individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK6852/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pdc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK6852/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DE0CCDFC83AB100000000078C037E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK6852_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK6852_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rab18-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK6852_"><span class="title" itemprop="name">Pyruvate Carboxylase Deficiency</span></h1><p class="contrib-group"><span itemprop="author">Dong Wang</span>, MD and <span itemprop="author">Darryl De Vivo</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK6852_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK6852_ai__"><div class="contrib half_rhythm"><span itemprop="author">Dong Wang</span>, MD<div class="affiliation small">Georgia Neurodiagnostic &#x00026; Treatment Center<br />Duluth, Georgia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@888666gnawd" class="oemail">moc.liamg@888666gnawd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Darryl De Vivo</span>, MD<div class="affiliation small">Departments of Pediatrics and Neurology<br />Columbia University <br />Neurological Institute of New York<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.aibmuloc@1dcd" class="oemail">ude.aibmuloc@1dcd</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 2, 2009</span>; Last Update: <span itemprop="dateModified">March 1, 2018</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pdc.Summary" itemprop="description"><h2 id="_pdc_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Pyruvate carboxylase (PC) deficiency is characterized in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized:</p><ul><li class="half_rhythm"><div>Type A (infantile form), in which most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children die in infancy or early childhood</div></li><li class="half_rhythm"><div>Type B (severe neonatal form), in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have hepatomegaly, pyramidal tract signs, and abnormal movement and die within the first three months of life</div></li><li class="half_rhythm"><div>Type C (intermittent/benign form), in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal or mildly delayed neurologic development and episodic metabolic acidosis</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of PC deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of PC enzyme deficiency in fibroblasts or lymphoblasts. In individuals with PC deficiency, fibroblast PC enzyme activity is usually less than 5% of that observed in controls. The diagnosis of PC deficiency can also be established in a proband by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PC</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Intravenous glucose-containing fluids, hydration, and correction of the metabolic acidosis are the mainstays of acute management. Correction of biochemical abnormalities and supplementation with citrate, aspartic acid, and biotin may improve somatic findings but not neurologic manifestations. Orthotopic liver transplantation may be indicated in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Anaplerotic therapies such as triheptanoin show some promise, especially regarding the neurologic manifestations, but need to be further evaluated.</p><p><i>Prevention of primary manifestations:</i> Parental education regarding factors that elicit a crisis and early signs of decompensation; written information on the child's disorder and appropriate emergency treatment to be carried at all times; minimization of intercurrent infections and environmental stressors; high-carbohydrate and high-protein diet with frequent feedings to prevent dependence on gluconeogenesis.</p><p><i>Prevention of secondary complications:</i> Hospitalization for the management of fever, infection, dehydration, or trauma; intensive proactive medical support to prevent dehydration, hypotension, hypoglycemia, and increasing metabolic acidosis.</p><p><i>Surveillance:</i> Regular monitoring of serum lactate concentrations.</p><p>Agents/circumstances to avoid: Fasting; the ketogenic diet.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>PC deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. <i>De novo</i> somatic pathogenic variants have been reported. If both parents are carriers, sibs of an individual with PC deficiency have a 25% chance of inheriting both pathogenic variants and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being carriers, and a 25% chance of inheriting both normal genes and not being carriers. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if both pathogenic variants have been identified in an affected family member.</p></div></div><div id="pdc.Diagnosis"><h2 id="_pdc_Diagnosis_">Diagnosis</h2><p>There are three clinical presentations of pyruvate carboxylase (PC) deficiency:</p><ul><li class="half_rhythm"><div>Type A. Infantile or North American form</div></li><li class="half_rhythm"><div>Type B. Severe neonatal or French form</div></li><li class="half_rhythm"><div>Type C. Intermittent/benign form</div></li></ul><div id="pdc.Suggestive_Findings"><h3>Suggestive Findings</h3><p>PC deficiency <b>should be suspected</b> in individuals with the following clinical features and biochemical findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Recurrent seizures</div></li></ul><p><b>Biochemical</b>
<b>findings by PC deficiency type</b> [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]</p><ul><li class="half_rhythm"><div><b>Type A.</b> Infantile-onset mild to moderate lactic acidemia; normal lactate-to-pyruvate ratio despite acidemia</div></li><li class="half_rhythm"><div><b>Type B.</b> Increased lactate-to-pyruvate ratio; decreased 3-hydroxybutyrate-to-acetoacetate ratio; elevated blood concentrations of citrulline, proline, lysine, and ammonia; low concentration of glutamine</div></li><li class="half_rhythm"><div><b>Type C.</b> Episodic metabolic acidosis with normal plasma citrulline concentrations and elevated plasma lysine and proline concentrations</div></li></ul><p><b>Biochemical abnormalities by <a class="def" href="/books/n/gene/glossary/def-item/analyte/">analyte</a>.</b> Note: For each of the following analytes the abnormal values overlap among PC deficiency types A, B, and C. Normal values differ by laboratory.</p><ul><li class="half_rhythm"><div><b>Lactate and pyruvate.</b> The lack of PC enzyme activity causes the accumulation of pyruvate in the plasma, which is subsequently converted to lactate by the enzyme lactate dehydrogenase, causing an elevated plasma concentration of lactic acid. Elevated blood lactate concentrations (5.5-27.8 mmol/L; normal range 0.5-2.2) are characteristically found in PC deficiency type A (2-10 mmol/L), type B (&#x0003e;10 mmol/L), and type C (2-5 mmol/L). Blood pyruvate concentrations are usually elevated in PC deficiency type B (0.14-0.90 mmol/L; normal range 0.04-0.13), resulting in an elevated lactate-to-pyruvate ratio (&#x0003e;20). The ratio is usually normal in PC deficiency type A and C (&#x0003c;20).</div></li><li class="half_rhythm"><div><b>Amino acids.</b> In serum and urine: high alanine, citrulline, and lysine; low aspartic acid and glutamine. Amino acid concentrations vary with the general metabolic state of the individual.</div><ul><li class="half_rhythm"><div>Hyperalaninemia as a result of pyruvate shunting</div></li><li class="half_rhythm"><div>Hypercitrullinemia and hyperlysinemia caused by the block in the urea cycle secondary to a low aspartic acid</div></li><li class="half_rhythm"><div>Low aspartic acid and glutamine as a result of deficiency in the oxaloacetate precursor</div></li></ul></li><li class="half_rhythm"><div><b>Ketonemia.</b> 3-hydroxybutyrate and acetoacetate concentrations are increased in blood. In PC deficiency type B, the ratio of acetoacetate to 3-hydroxybutyrate is increased, reflecting a low NADH-to-NAD ratio inside the mitochondria. Lack of oxaloacetate prevents the liver from oxidizing acetyl-CoA derived from pyruvate and fatty acids. The expanded acetyl-CoA pool results in hepatic ketone body synthesis [<a class="bk_pop" href="#pdc.REF.de_vivo.1977.1281">De Vivo et al 1977</a>].</div></li><li class="half_rhythm"><div><b>Hypoglycemia.</b> Oxaloacetate deficiency limits gluconeogenesis. Note: Hypoglycemia is not a consistent finding despite the fact that PC is the first rate-limiting step in gluconeogenesis.</div></li><li class="half_rhythm"><div><b>Hyperammonemia</b> results from poor ammonia disposal and decreased urea cycle function.</div></li><li class="half_rhythm"><div><b>Cerebrospinal fluid (CSF)</b></div><ul><li class="half_rhythm"><div>Elevated lactate and pyruvate concentrations</div></li><li class="half_rhythm"><div>Markedly reduced glutamine concentration</div></li><li class="half_rhythm"><div>Elevated glutamic acid and proline concentrations</div></li></ul></li></ul></div><div id="pdc.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of PC deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of PC enzyme deficiency in fibroblasts or lymphoblasts by PC enzyme assay. In individuals with PC deficiency, fibroblast PC enzyme activity is usually less than 5% of that observed in controls [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]. Note: Muscle PC activity is quite low in control tissue. Therefore, PC enzyme assay on muscle tissue is not recommended.</p><p>The diagnosis of PC deficiency can also be <b>established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PC</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK6852/table/pdc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpdcTmoleculargenetictestingusedin" rid-ob="figobpdcTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PC</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Note: (1) Pathogenic variants have been found to be mosaic, an unusual occurrence in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder (see <a href="#pdc.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a> and <a href="#pdc.Molecular_Genetics">Molecular Genetics</a>). (2) Since PC deficiency occurs through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism, testing for intragenic deletions or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> could identify a disease-causing variant; such a variant has not been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PC</i> and other genes of interest (see <a href="#pdc.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="pdc.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Pyruvate Carboxylase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6852/table/pdc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pdc.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method&#x000a0;<sup>2</sup></th><th id="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PC</i></td><td headers="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_pdc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pdc.TF.1.1"><p class="no_margin">See <a href="/books/NBK6852/#pdc.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="pdc.TF.1.2"><p class="no_margin">The presence of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> may complicate molecular testing; see <a href="#pdc.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">Table 2</a>, and <a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al [2008]</a>.</p></div></dd><dt>3. </dt><dd><div id="pdc.TF.1.3"><p class="no_margin">See <a href="#pdc.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="pdc.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="pdc.TF.1.5"><p class="no_margin">Sequence analysis of the <i>PC</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> and promoter detects pathogenic variants in 95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, including the most common pathogenic variants: <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ala610Thr</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Arg631Gln</a>, and <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ala847Val</a>.</p></div></dd><dt>6. </dt><dd><div id="pdc.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="pdc.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="pdc.Clinical_Characteristics"><h2 id="_pdc_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pdc.Clinical_Description"><h3>Clinical Description</h3><p>Most individuals with pyruvate carboxylase (PC) deficiency present with failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Hypoglycemia is an inconsistent finding.</p><p>Three types of PC deficiency have been recognized, based on clinical presentation.</p><p><b>Type A (infantile form)</b> is characterized by infantile onset with mild metabolic acidosis, delayed motor development, intellectual disability, failure to thrive, apathy, hypotonia, pyramidal tract signs, ataxia, nystagmus, and convulsions.</p><p>Episodes of acute vomiting, tachypnea, and acidosis are usually precipitated by metabolic or infectious stress.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children die in infancy or early childhood, although some may survive to maturity. Older individuals function at a lower-than-average level and need special care and schooling [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><p><b>Type B (severe neonatal form).</b> Affected infants present with biochemical abnormalities, hypoglycemia, hyperammonemia, hypernatremia, anorexia, hepatomegaly, convulsions, stupor, hypotonia, pyramidal tract signs, abnormal movements (including high-amplitude tremor and dyskinesia), and abnormal ocular behavior.</p><p>Motor development is severely retarded and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have intellectual disability [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><p>The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants die within the first three months of life [<a class="bk_pop" href="#pdc.REF.garc_acazorla.2006.121">Garc&#x000ed;a-Cazorla et al 2006</a>]; however, two affected individuals were alive at ages nine and 20 years, likely because of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>] (see <a href="#pdc.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p><b>Type C (intermittent/benign form)</b> is characterized by normal or mildly delayed neurologic development and episodic metabolic acidosis. Five <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported [<a class="bk_pop" href="#pdc.REF.van_coster.1991.1">Van Coster et al 1991</a>, <a class="bk_pop" href="#pdc.REF.stern.1995.85">Stern et al 1995</a>, <a class="bk_pop" href="#pdc.REF.vaquerizo_madrid.1997.663">Vaquerizo Madrid et al 1997</a>, <a class="bk_pop" href="#pdc.REF.arnold.2001.519">Arnold et al 2001</a>, <a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]. The first individual described had normal mental and motor development at age 12 years despite several earlier episodes of metabolic acidosis [<a class="bk_pop" href="#pdc.REF.van_coster.1991.1">Van Coster et al 1991</a>].</p><p><b>Brain MRI.</b> Symmetric cystic lesions and gliosis in the cortex, basal ganglia, brain stem, or cerebellum; generalized hypomyelination; and hyperintensity of the subcortical frontoparietal white matter were described in some individuals with type A.</p><p>Ventricular dilation, cerebrocortical and white matter atrophy, or periventricular white matter cysts have been reported in some individuals with type B [<a class="bk_pop" href="#pdc.REF.garc_acazorla.2006.121">Garc&#x000ed;a-Cazorla et al 2006</a>].</p><p><b>Magnetic resonance spectroscopy (MRS).</b> Brain MRS shows high levels for lactate and choline and low levels for <i>N</i>-acetylaspartate.</p><p><b>Pathophysiology.</b> The glutamine-glutamate cycle in astrocytes requires a continuous supply of oxaloacetate provided by the reaction catalyzed by PC enzyme activity.</p></div><div id="pdc.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b>Type A.</b> Seven pathogenic variants (<a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Arg62Cys</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Val145Ala</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Arg451Cys</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ala610Thr</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Arg631Gln</a>, <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Met743Ile</a>, and <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ala847Val</a>) have been identified in five individuals [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><p><b>Type B.</b> Missense variants, deletions, and splice donor site pathogenic variants occur in homozygotes, compound heterozygotes, and individuals with <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> (see <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">Table 2</a>) [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><p><b>Type C.</b> A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variant (<a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ser266Ala</a>) and somatic mosaic variant (<a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ser705Ter</a>) were observed in the first individual described [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]; compound heterozygosity for the pathogenic variants <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Thr569Ala</a> and <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">Leu1137ValfsTer1170</a> was observed in the second individual described [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><p><b>Mosaicism</b> (see <a href="#pdc.Molecular_Genetics">Molecular Genetics</a>) was found in five individuals [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>: Table 2 (type A: #6; type B: #2, #5, and #7; type C: #1)]. Four had prolonged survival; the fifth (type B: #7) died from unrelated medical complications.</p><p><b>Homozygous pathogenic variants.</b> The deaths of the more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with type B correlated with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> variants, which produced very low amounts (2% and 3%) of fibroblast PC protein [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>: Table 2].</p></div><div id="pdc.Prevalence"><h3>Prevalence</h3><p>In most populations, the birth incidence of PC deficiency is low (1:250,000).</p><p>PC deficiency is more prevalent in particular ethnic groups:</p><ul><li class="half_rhythm"><div><b>Type A.</b> Incidence is increased among the native North American Ojibwa, Cree, and Micmac tribes of the Algonquin-speaking peoples. The <a class="figpopup" href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object" rid-figpopup="figpdcTpcvariantsdiscussedinthisgene" rid-ob="figobpdcTpcvariantsdiscussedinthisgene">p.Ala610Thr</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in all 13 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of Ojibwa and Cree origin. In those populations the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency may be as high as 1:10 [<a class="bk_pop" href="#pdc.REF.carbone.1998.1312">Carbone et al 1998</a>].</div></li><li class="half_rhythm"><div><b>Type B.</b> Incidence is increased in Europe (France especially, but also Germany and England).</div></li></ul></div></div><div id="pdc.Genetically_Related_Allelic_Disorder"><h2 id="_pdc_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>PC</i>.</p></div><div id="pdc.Differential_Diagnosis"><h2 id="_pdc_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/biotin/"><b>Biotinidase deficiency</b></a> results from the inability to recycle endogenous biotin and to use protein-bound biotin from the diet. Biotin binds to propionyl-coenzyme A-carboxylase, pyruvate carboxylase (PC), beta-methylcrotonyl-CoA carboxylase, and acetyl-CoA carboxylase. Deficiency affects all biotinylated enzymes and can present in the neonatal period or later in infancy with neurologic symptoms such as lethargy, seizures with metabolic acidosis, hearing loss, alopecia, and perioral/facial dermatitis. It can be effectively treated with biotin.</p><p>In the untreated state, profound biotinidase deficiency during infancy is usually characterized by neurologic and cutaneous findings that include seizures, hypotonia, and rash, often accompanied by hyperventilation, laryngeal stridor, and apnea. Older children may also have alopecia, ataxia, developmental delay, sensorineural hearing loss, optic atrophy, and recurrent infections. Individuals with partial biotinidase deficiency may have hypotonia, skin rash, and hair loss, particularly during times of stress.</p><p>Biotinidase deficiency is caused by pathogenic variants in <i>BTD.</i> Individuals with profound biotinidase deficiency have less than 10% of mean normal serum biotinidase activity; individuals with partial biotinidase deficiency have 10%-30% of mean normal serum biotinidase activity.</p><p>Biotinidase deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Pyruvate dehydrogenase complex (PDHC) deficiency</b> (OMIM <a href="http://omim.org/phenotypicSeries/PS312170" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS312170</a>) results from deficiency of either one of three catalytic components (E1, E2, and E3) or the regulatory component of PDHC (pyruvate dehydrogenase phosphate phosphatase). The diagnosis of PDHC deficiency is suspected in individuals with lactic acidemia who have a progressive or intermittent neurologic syndrome including: poor acquisition or loss of motor milestones, poor muscle tone, new-onset seizures, periods of incoordination (i.e., ataxia), abnormal eye movements, poor response to visual stimuli, and episodic dystonia. Blood and CSF lactate concentrations are elevated and are associated with elevations of blood and CSF concentrations of pyruvate and alanine. Blood glucose values are normal and decline only slowly with fasting because of increased pyruvate carboxylation and gluconeogenesis. Blood ketone bodies are usually not detectable, unlike PC deficiency. Also, unlike PC deficiency, PDHC deficiency usually presents with a normal lactate-to-pyruvate ratio in plasma. Typically, the CSF lactate elevations are higher than those in the blood, giving rise to the term "cerebral lactic acidosis."</p><p>Brain MRI may show varying combinations of ventricular dilatation; cerebral atrophy; hydrocephaly; partial or complete absence of the corpus callosum; absence of the medullary pyramids; abnormal and ectopic inferior olives; symmetric cystic lesions; gliosis in the cortex, basal ganglia, brain stem, or cerebellum; and generalized hypomyelination.</p><p>Brain MRS shows high lactate concentrations (giving rise to the term "cerebral lactic acidosis") and low <i>N</i>-acetylaspartate and choline concentrations consistent with hypomyelination.</p><p>PDHC enzyme assay, immunoblotting analysis, and <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of two of the genes known to be associated with this disorder, <i>PDHA1</i> and <i>DLAT</i>, can help establish the diagnosis.</p><p><b>Respiratory chain disorder</b> may result from pathogenic variants in nuclear genes or mitochondrial genes that encode any one of the five respiratory chain complexes. Lactate and pyruvate concentrations are elevated, and the lactate/pyruvate ratio is elevated, often above 20. Biopsied skeletal muscle may reveal ragged-red fibers, cytochrome <i>c</i>-oxidase negative fibers, and succinate dehydrogenase intensely positive fibers. These histologic abnormalities are commonly seen with pathogenic nuclear DNA variants causing intergenomic signaling defects and pathogenic mitochondrial DNA variants affecting protein synthesis genes. Brain MRI may reveal distinctive abnormalities, as described with <a href="/books/n/gene/narp/">Leigh syndrome</a> or mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (<a href="/books/n/gene/melas/">MELAS</a>) [<a class="bk_pop" href="#pdc.REF.dimauro.2008.91">DiMauro &#x00026; Schon 2008</a>]. Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variants are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or dominant manner; mitochondrial DNA variants are inherited as maternal, non-Mendelian traits.</p><p><b>Krebs cycle disorders</b> are rare and the enzymyopathies are partial. Lactate and pyruvate concentrations are elevated and the lactate/pyruvate ratio is normal. Urine organic acid profile may reveal distinctive elevation of fumaric acid or other Krebs cycle intermediates, reflecting the site of the enzyme deficiency.</p><p><b>Gluconeogenic defects</b> may be aggravated clinically by fasting. Blood lactate, pyruvate, and alanine concentrations are classically elevated with clinical symptoms, and blood glucose concentration is low, indicating glycogen depletion and gluconeogenic pathway block. Ketone bodies are elevated, reflecting a physiologic response to fasting, stress, and hypoglycemia.</p><p><a href="/books/n/gene/ca5a-def/"><b>Carbonic anhydrase VA deficiency</b></a> is suspected in children with neonatal, infantile, or early-childhood metabolic hyperammonemic encephalopathy combined with hyperlactatemia and metabolites suggestive of multiple carboxylase deficiency. The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with these metabolic findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CA5A</i>.</p></div><div id="pdc.Management"><h2 id="_pdc_Management_">Management</h2><div id="pdc.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with pyruvate carboxylase (PC) deficiency, the evaluations summarized in this section are recommended (if not performed as part of the evaluation that led to the diagnosis):</p><ul><li class="half_rhythm"><div>Blood, urine, and CSF measures of organic and amino acids; brain MRI and MRS analysis</div></li><li class="half_rhythm"><div>Evaluation by a pediatric neurologist skilled in metabolic and genetic disorders to confirm the diagnosis, guide the treatment, and determine the prognosis</div></li><li class="half_rhythm"><div>Genetic counseling for the parents regarding the risk of recurrence in future pregnancies</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="pdc.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment focuses on providing alternative energy sources, hydration, and correction of the metabolic acidosis during acute decompensation. Stimulating residual PC enzyme activity is an important goal for long-term stable metabolic status. Correction of the biochemical abnormality can reverse some symptoms, but central nervous system damage progresses regardless of treatment [<a class="bk_pop" href="#pdc.REF.dimauro.1999">DiMauro &#x00026; De Vivo 1999</a>].</p><p>"Anaplerotic therapy" is based on the concept that an energy deficit in these diseases could be improved by providing alternative substrate for both the citric acid cycle and the electron transport chain for enhanced ATP production [<a class="bk_pop" href="#pdc.REF.roe.2006.332">Roe &#x00026; Mochel 2006</a>].</p><ul><li class="half_rhythm"><div>Citrate supplementation reduces the acidosis and provides substrate for the citric acid cycle [<a class="bk_pop" href="#pdc.REF.ahmad.1999.331">Ahmad et al 1999</a>].</div></li><li class="half_rhythm"><div>Aspartic acid supplementation allows the urea cycle to proceed and reduces the plasma and urine ammonia concentrations but has little effect on the neurologic disturbances as the aspartate does not enter the brain freely [<a class="bk_pop" href="#pdc.REF.ahmad.1999.331">Ahmad et al 1999</a>]. Lowering the body ammonia burden may mitigate the neurologic insult.</div></li><li class="half_rhythm"><div>Biotin supplementation is given to help optimize the residual PC enzyme activity but is usually of little efficacy.</div></li><li class="half_rhythm"><div>Triheptanoin, an odd-carbon triglyceride, providing a source for acetyl-CoA and anaplerotic propionyl-CoA, has been tried in one individual with biotin-unresponsive PC deficiency type B with immediate reversal (&#x0003c;48 h) of major hepatic failure and full correction of all biochemical abnormalities [<a class="bk_pop" href="#pdc.REF.mochel.2005.305">Mochel et al 2005</a>, <a class="bk_pop" href="#pdc.REF.mochel.2017">Mochel 2017</a>]. Triheptanoin provides C5-ketone bodies that can cross the blood-brain barrier, therefore providing substrates for the brain. Dietary intervention with triheptanoin is the only therapeutic approach that showed improvement of brain metabolism. However, this observation needs to be confirmed in additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Orthotopic liver transplantation has reversed the biochemical abnormalities in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#pdc.REF.nyhan.2002.143">Nyhan et al 2002</a>].</div></li></ul></div><div id="pdc.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>Educate parents about the factors that elicit a crisis and the early signs of decompensation.</p><p>Carry written information regarding the child's disorder and appropriate treatment in an emergency setting.</p><p>Minimize intercurrent infections and environmental stressors.</p><p>Provide a high-carbohydrate and high-protein diet with frequent feedings to help prevent dependence on gluconeogenesis.</p></div><div id="pdc.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Individuals with PC deficiency are very brittle metabolically. Intensive medical support is indicated proactively to prevent dehydration, hypotension, hypoglycemia, and increasing metabolic acidosis. Hospitalization is indicated for the management of fever, infection, dehydration, or trauma. The ketogenic diet is an absolute contraindication, shown to worsen the acidosis into a life-threatening range.</p></div><div id="pdc.Surveillance"><h3>Surveillance</h3><p>Monitor lactate levels regularly.</p></div><div id="pdc.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Fasting</div></li><li class="half_rhythm"><div>The ketogenic diet, which aggravates life-threatening metabolic acidosis</div></li></ul></div><div id="pdc.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#pdc.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pdc.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy in a woman with PC deficiency has not been reported. However, women with the benign form (type C) could become pregnant; such a pregnancy should be closely monitored for any metabolic derangements including dehydration and acidosis.</p></div><div id="pdc.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Thiamine and lipoic acid could optimize pyruvate dehydrogenase complex (PDHC) activity, which could help reduce the plasma and urine pyruvate and lactate concentrations through an alternate route of pyruvate metabolism. Theoretically, this intervention could increase the acetyl-CoA pool and worsen the ketonemia.</p><ul><li class="half_rhythm"><div>An individual with PC deficiency was responsive to treatment with thiamine.</div></li><li class="half_rhythm"><div>Two sisters with PC deficiency, severe intellectual disability and motor retardation, and <a href="/books/n/gene/kss/">Leigh syndrome</a> improved clinically and biochemically after treatment with thiamine and lipoic acid. The precise molecular diagnosis in these individuals is uncertain.</div></li></ul><p>Based on reports from the literature [<a class="bk_pop" href="#pdc.REF.nyhan.2002.143">Nyhan et al 2002</a>, <a class="bk_pop" href="#pdc.REF.mochel.2005.305">Mochel et al 2005</a>], it has been suggested that a combination of orthotopic liver transplantation and anaplerotic diet be used in order to obtain both (i) long-term metabolic stability and (ii) improvement/correction of brain energy metabolism, myelination, and neurotransmission.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="pdc.Genetic_Counseling"><h2 id="_pdc_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pdc.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Pyruvate carboxylase (PC) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="pdc.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In most instances, the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are heterozygotes (i.e., carriers of one <i>PC</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>In rare cases, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a> and one pathogenic variant inherited from a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> parent [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]; in these families, presumably only one parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PC</i> pathogenic variant.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If both parents are carriers, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of inheriting both pathogenic variants, a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and a 25% chance of inheriting neither pathogenic variant.</div></li><li class="half_rhythm"><div>If only one parent is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (i.e., the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for an inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a>), the sibs of a proband have a 50% chance of inheriting one pathogenic variant and a 50% chance of not inheriting a pathogenic variant.</div></li><li class="half_rhythm"><div>Sibs who inherit two pathogenic variants will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Sibs who inherit one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (heterozygotes) are expected to be asymptomatic. A sib who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an inherited pathogenic variant could be affected if s/he has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> somatic <i>PC</i> pathogenic variant.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of a proband are typically <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="pdc.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>PC</i> pathogenic variants in the family.</p><p>Biochemical genetic testing for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status is not reliable.</p></div><div id="pdc.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pdc.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>PC</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for PC and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="pdc.Resources"><h2 id="_pdc_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=pyruvatecarboxylasedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Pyruvate carboxylase deficiency</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>Association for Neuro-Metabolic Disorders (ANMD)</b></div><div>5223 Brookfield Lane</div><div>Sylvania OH 43560-1809</div><div><b>Phone:</b> 419-885-1809; 419-885-1497</div><div><b>Email:</b> volk4olks@aol.com</div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="pdc.Molecular_Genetics"><h2 id="_pdc_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pdc.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Pyruvate Carboxylase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6852/table/pdc.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pdc.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pdc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pdc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pdc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pdc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pdc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pdc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pdc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5091" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PC</i></a></td><td headers="hd_b_pdc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5091" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pdc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P11498" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Pyruvate carboxylase, mitochondrial</a></td><td headers="hd_b_pdc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PC database</a></td><td headers="hd_b_pdc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PC</a></td><td headers="hd_b_pdc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PC</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pdc.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pdc.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Pyruvate Carboxylase Deficiency (<a href="/omim/266150,608786" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6852/table/pdc.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pdc.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/266150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">266150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PYRUVATE CARBOXYLASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608786" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608786</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PYRUVATE CARBOXYLASE; PC</td></tr></tbody></table></div></div><div id="pdc.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Pyruvate carboxylase (PC) [EC 6.4.1.1] is a biotin-dependent mitochondrial enzyme that plays an important role in energy production and anaplerotic pathways. PC catalyzes the conversion of pyruvate to oxaloacetate (see <a class="figpopup" href="/books/NBK6852/figure/pdc.F1/?report=objectonly" target="object" rid-figpopup="figpdcF1" rid-ob="figobpdcF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpdcF1" co-legend-rid="figlgndpdcF1"><a href="/books/NBK6852/figure/pdc.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figpdcF1" rid-ob="figobpdcF1"><img class="small-thumb" src="/books/NBK6852/bin/pdc-Image001.gif" src-large="/books/NBK6852/bin/pdc-Image001.jpg" alt="Figure 1. . Diagrammatic representation of metabolic pathway affected by PC deficiency." /></a><div class="icnblk_cntnt" id="figlgndpdcF1"><h4 id="pdc.F1"><a href="/books/NBK6852/figure/pdc.F1/?report=objectonly" target="object" rid-ob="figobpdcF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Diagrammatic representation of metabolic pathway affected by PC deficiency. The PC enzyme is indicated by the red oval; the dotted arrow lines represent absent pathways. </p></div></div><p><b>Gene structure.</b>
<i>PC</i> contains 20 coding exons and four non-coding exons at the 5'-UTR [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]. All four non-coding exons are involved in alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, resulting in three tissue-specific PC transcripts carrying the same <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>: variant 1 (4004 bp, <a href="/nuccore/NM_000920.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000920.3</a>), variant 2 (3959 bp, <a href="/nuccore/NM_022172.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022172.2</a>), and variant 3 (4192 bp, <a href="/nuccore/NM_001040716.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001040716.1</a>) (<a class="figpopup" href="/books/NBK6852/figure/pdc.F2/?report=objectonly" target="object" rid-figpopup="figpdcF2" rid-ob="figobpdcF2">Figure 2</a>). Southern blotting of human <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA showed that <i>PC</i> exists in a single copy and no pseudogenes are detected. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK6852/#pdc.molgen.TA">Table A</a>, <b>Gene</b>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpdcF2" co-legend-rid="figlgndpdcF2"><a href="/books/NBK6852/figure/pdc.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figpdcF2" rid-ob="figobpdcF2"><img class="small-thumb" src="/books/NBK6852/bin/pdc-Image002.gif" src-large="/books/NBK6852/bin/pdc-Image002.jpg" alt="Figure 2. . PC structure and three transcript variants." /></a><div class="icnblk_cntnt" id="figlgndpdcF2"><h4 id="pdc.F2"><a href="/books/NBK6852/figure/pdc.F2/?report=objectonly" target="object" rid-ob="figobpdcF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin"><i>PC</i> structure and three transcript variants. The coding exons of <i>PC</i> are represented by rectangles with different patterns and Arabic numbers on the top. The four untranslated exons (UEs) are labeled UE1-UE4 (top left). The arrows before UE1, UE2, and UE4 <a href="/books/NBK6852/figure/pdc.F2/?report=objectonly" target="object" rid-ob="figobpdcF2">(more...)</a></p></div></div><p><b>Pathogenic variants.</b> Missense, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants in <i>PC</i> are associated with PCD. Mosaicism, in which the abnormal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> was typically present in a greater proportion than the normal allele, was found in five individuals [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>]. Four had prolonged survival.</p><p>Of note, two substitutions &#x02013; c.1892G&#x0003e;A (p.Arg631Gln) and c.2549C&#x0003e;T (p.Ala847Val) &#x02013; were found in a mosaic state on the same <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in three individuals [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p><div id="pdc.T.pc_variants_discussed_in_this_gene" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>PC</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6852/table/pdc.T.pc_variants_discussed_in_this_gene/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pdc.T.pc_variants_discussed_in_this_gene_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.184C&#x0003e;T</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg62Cys</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000920.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000920<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?val=NP_000911.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000911<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.434T&#x0003e;C</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val145Ala</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.796T&#x0003e;A</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser266Ala</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1351C&#x0003e;T</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg451Cys</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1705A&#x0003e;G</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr569Ala</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1828G&#x0003e;A</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala610Thr</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1892G&#x0003e;A</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg631Gln&#x000a0;<sup>1,&#x000a0;2</sup></td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2114C&#x0003e;A</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser705Ter&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2229G&#x0003e;T</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met743Ile</td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2540C&#x0003e;T</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala847Val&#x000a0;<sup>1,&#x000a0;2</sup></td></tr><tr><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3499-3500delCT</td><td headers="hd_h_pdc.T.pc_variants_discussed_in_this_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu1137ValfsTer1170</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="pdc.TF.2.1"><p class="no_margin">Indicates the mosaic state of this <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a></p></div></dd><dt>2. </dt><dd><div id="pdc.TF.2.2"><p class="no_margin">These variants have been observed <i>in cis.</i></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein consists of 1,178 amino acids with a molecular weight of approximately 125 kd. It consists of a homotetramer of polypeptides, each covalently bound to a biotin molecule and processing both the catalytic and regulatory functions.</p><p>PC (EC 6.4.1.1, PC) normally serves an anaplerotic function by replenishing the Krebs cycle intermediates. PC catalyzes the conversion of pyruvate to oxaloacetate; this reaction is allosterically activated by elevated acetyl-coenzyme A levels (<a class="figpopup" href="/books/NBK6852/figure/pdc.F1/?report=objectonly" target="object" rid-figpopup="figpdcF1" rid-ob="figobpdcF1">Figure 1</a>). The anaplerotic function of PC is important for the biosynthesis of neurotransmitters in the central nervous system, as well as energy metabolism. PC also controls the first step of hepatic gluconeogenesis and is important in lipogenesis.</p><p>The enzyme is localized within the mitochondrial matrix in many tissues. Expression is highest in the liver, kidney, adipose tissue, pancreatic islets, and lactating mammary gland. Expression is moderate in brain, heart, and adrenal gland, and lowest in white blood cells and skin fibroblasts [<a class="bk_pop" href="#pdc.REF.jitrapakdee.1999.1">Jitrapakdee &#x00026; Wallace 1999</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss of protein function may occur from loss of <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> expression or loss or reduction of functional activity of PC. Individuals with mosaic pathogenic variants retained greater enzyme activity than those with non-mosaic pathogenic variants [<a class="bk_pop" href="#pdc.REF.wang.2008.31">Wang et al 2008</a>].</p></div></div><div id="pdc.References"><h2 id="_pdc_References_">References</h2><div id="pdc.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.ahmad.1999.331">Ahmad A, Kahler SG, Kishnani PS, Artigas-Lopez M, Pappu AS, Steiner R, Millington DS, Van Hove JL. Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">87</span>:331–8.</span> [<a href="/pubmed/10588840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10588840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.arnold.2001.519">Arnold GL, Griebel ML, Porterfield M, Brewster M. Pyruvate carboxylase deficiency. Report of a case and additional evidence for the "mild" phenotype. <span><span class="ref-journal">Clin Pediatr (Phila). </span>2001;<span class="ref-vol">40</span>:519–21.</span> [<a href="/pubmed/11583052" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11583052</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.carbone.1998.1312">Carbone MA, MacKay N, Ling M, Cole DE, Douglas C, Rigat B, Feigenbaum A, Clarke JT, Haworth JC, Greenberg CR, Seargeant L, Robinson BH. Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:1312–9.</span> [<a href="/pmc/articles/PMC1377163/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377163</span></a>] [<a href="/pubmed/9585612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9585612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.de_vivo.1977.1281">De Vivo DC, Haymond MW, Leckie MP, Bussman YL, McDougal DB Jr, Pagliara AS. The clinical and biochemical implications of pyruvate carboxylase deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1977;<span class="ref-vol">45</span>:1281–96.</span> [<a href="/pubmed/412860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 412860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.dimauro.1999">DiMauro S, De Vivo DC. Diseases of carbohydrate, fatty acid and mitochondrial metabolism. In: Siegel J, ed. <em>Basic Neurochemistry: Molecular, Cellular and Medical Aspects</em>. Philadelphia, PA: Lippincott-Raven Publishers; 1999:841-63.</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.dimauro.2008.91">DiMauro S, Schon EA. Mitochondrial disorders in the nervous system. <span><span class="ref-journal">Annu Rev Neurosci. </span>2008;<span class="ref-vol">31</span>:91–123.</span> [<a href="/pubmed/18333761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18333761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.garc_acazorla.2006.121">Garc&#x000ed;a-Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray JM. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:121–7.</span> [<a href="/pubmed/16278852" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16278852</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.jitrapakdee.1999.1">Jitrapakdee S, Wallace JC. Structure, function and regulation of pyruvate carboxylase. <span><span class="ref-journal">Biochem J. </span>1999;<span class="ref-vol">340</span>:1–16.</span> [<a href="/pmc/articles/PMC1220216/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1220216</span></a>] [<a href="/pubmed/10229653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10229653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.mochel.2017">Mochel F (2017) Triheptanoin for the treatment of brain energy deficit: a 14-year experience. <a href="https://www.ncbi.nlm.nih.gov/pubmed/28688166" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">J Neurosci Res.</a>95:2236-43. [<a href="/pubmed/28688166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28688166</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.mochel.2005.305">Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, Rabier D, Roe CR, Saudubray JM. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">84</span>:305–12.</span> [<a href="/pubmed/15781190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15781190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.nyhan.2002.143">Nyhan WL, Khanna A, Barshop BA, Naviaux RK, Precht AF, Lavine JE, Hart MA, Hainline BE, Wappner RS, Nichols S, Haas RH. Pyruvate carboxylase deficiency--insights from liver transplantation. <span><span class="ref-journal">Mol Genet Metab. </span>2002;<span class="ref-vol">77</span>:143–9.</span> [<a href="/pubmed/12359142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12359142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.roe.2006.332">Roe CR, Mochel F. Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. <span><span class="ref-journal">J Inherit Metab Dis. </span>2006;<span class="ref-vol">29</span>:332–40.</span> [<a href="/pubmed/16763896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16763896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.stern.1995.85">Stern HJ, Nayar R, Depalma L, Rifai N. Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblasts. <span><span class="ref-journal">Clin Biochem. </span>1995;<span class="ref-vol">28</span>:85–9.</span> [<a href="/pubmed/7720232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7720232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.van_coster.1991.1">Van Coster RN, Fernhoff PM, De Vivo DC. Pyruvate carboxylase deficiency: a benign variant with normal development. <span><span class="ref-journal">Pediatr Res. </span>1991;<span class="ref-vol">30</span>:1–4.</span> [<a href="/pubmed/1909777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1909777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.vaquerizo_madrid.1997.663">Vaquerizo Madrid J, Val Sanchez de Leon JM, Sanchez Alarcon J, Remon Alvarez-Arenas J. Congenital oculomotor apraxia and partial deficiency of pyruvate carboxylase. <span><span class="ref-journal">An Esp Pediatr. </span>1997;<span class="ref-vol">47</span>:663–4.</span> [<a href="/pubmed/9575131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9575131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.wang.2008.31">Wang D, Yang H, De Braganca KC, Lu J, Yu Shih L, Briones P, Lang T, De Vivo DC. The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survival. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">95</span>:31–8.</span> [<a href="/pmc/articles/PMC2572257/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2572257</span></a>] [<a href="/pubmed/18676167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18676167</span></a>]</div></li></ul></div><div id="pdc.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.h_berle.2013.101">H&#x000e4;berle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. <span><span class="ref-journal">Arch Biochem Biophys. </span>2013;<span class="ref-vol">536</span>:101–8.</span> [<a href="/pubmed/23628343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23628343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.shah.2013.7423">Shah GN, Rubbelke TS, Hendin J, Nguyen H, Waheed A, Shoemaker JD, Sly WS. Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both in ammonia detoxification and glucose metabolism. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2013;<span class="ref-vol">110</span>:7423–8.</span> [<a href="/pmc/articles/PMC3645511/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3645511</span></a>] [<a href="/pubmed/23589845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23589845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.van_karnebeek.2014.428">van Karnebeek CDM, Shevell MI, Zschocke J, Moeschler J, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">111</span>:428–38.</span> [<a href="/pubmed/24518794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24518794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pdc.REF.van_karnebeek.2014.453">van Karnebeek CDM, Sly WS, Ross CJ, Salvarinova R, Yaplito-Lee J, Santra S, Shyr C, Horvath GA, Eydoux P, Lehman AM, Bernard V, Newlove T, Ukpeh H, Chakrapani A, Preece MA, Ball S, Pitt J, Vallance HD, Coulter-Mackie M, Nguyen H, Zhang L-H, Bhavsar AP, Sinclair G, Waheed A, Wasserman WW, Stockler-Ipsiroglu S. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:453–61.</span> [<a href="/pmc/articles/PMC3951944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3951944</span></a>] [<a href="/pubmed/24530203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24530203</span></a>]</div></li></ul></div></div><div id="pdc.Chapter_Notes"><h2 id="_pdc_Chapter_Notes_">Chapter Notes</h2><div id="pdc.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 March 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 July 2015 (bp/ctf) Revision: CA-VA added to Differential Diagnosis</div></li><li class="half_rhythm"><div>24 July 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 July 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 June 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>7 March 2005 (ddv) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK6852</span><span class="label">PMID: <a href="/pubmed/20301764" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301764</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rab18-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK6852&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK6852/?report=reader">PubReader</a></li><li><a href="/books/NBK6852/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK6852" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK6852" style="display:none" title="Cite this Page"><div class="bk_tt">Wang D, De Vivo D. Pyruvate Carboxylase Deficiency. 2009 Jun 2 [Updated 2018 Mar 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK6852/pdf/Bookshelf_NBK6852.pdf">PDF version of this page</a> (469K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pdc.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pdc.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pdc.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pdc.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pdc.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pdc.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pdc.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pdc.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pdc.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pdc.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pdc.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5091[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PC</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK6852+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1521768" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1521768" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1521768" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1521768" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25032271" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dihydrolipoamide Dehydrogenase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dihydrolipoamide Dehydrogenase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31804789" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bijarnia-Mahay S, Bhatia S, Arora V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301764" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301764" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9349dde0891169b6e075">Pyruvate Carboxylase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Pyruvate Carboxylase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:24:25-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DE0CCDFC83AB100000000078C037E&amp;ncbi_session=CE8DE0CCDFC93481_1932SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK6852%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK6852&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK6852/&amp;ncbi_pagename=Pyruvate Carboxylase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DE0CCDFC93481_1932SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>